Palmitoylethanolamide in the Treatment of Failed Back Surgery Syndrome.
Antonella PaladiniGuistino VarassiGiuseppe BentivegnaSandro CarlettiAlba PiroliStefano CoaccioliPublished in: Pain research and treatment (2017)
This observational study provides evidence, albeit preliminary, for the efficacy and safety of um-PEA (Normast) as part of a multimodal therapeutic regimen in the treatment of pain-resistant patients suffering from failed back surgery syndrome.